Peptide Storage and Stability: What Actually Degrades, and When

Peptides degrade through a small number of specific reactions — deamidation, oxidation, hydrolysis, disulfide scrambling, aggregation and adsorption. How to tell which apply to your sequence.

Peptide storage advice usually stops at “keep it cold and away from light.” That is correct but not useful, because it does not tell you what goes wrong, which peptides it happens to, or how fast. Peptide storage failure is nothing like food spoiling. They degrade through a small number of specific chemical reactions, and knowing which ones apply to your compound tells you how careful you actually need to be.

The short version
  • Lyophilised powder at −20 °C is stable for a long time. Solution is where the clock starts.
  • The main routes are deamidation, oxidation, hydrolysis, disulfide scrambling, aggregation and surface adsorption.
  • Which ones matter depends on the sequence. Look at your peptide’s residues and you can predict its weak points.
  • Freeze–thaw cycling is more damaging than simply being refrigerated. Aliquot once.
Peptide storage: Hospira Bacteriostatic Water 30ml vial from Soraci Labs, for laboratory research use only
Hospira Bacteriostatic Water 30ml — sold for laboratory research use only.

Deamidation — the most common peptide storage failure

Asparagine and glutamine carry amide side chains. Those amides hydrolyse to the corresponding acids, converting Asn to aspartate and Gln to glutamate, and changing the molecule’s charge in the process.

Asparagine is far more vulnerable than glutamine, and the residue that follows it matters enormously. Asn-Gly is the classic liability: glycine has no side chain, so nothing blocks the cyclic succinimide intermediate that drives the reaction. Asn followed by a bulky residue is much more stable.

Deamidation is base-catalysed and accelerates sharply above neutral pH. This is one reason a mildly acidic diluent is not the problem people assume it is.

Oxidation — sequence-specific and often overlooked

Three residues are oxidation-prone: methionine (to the sulfoxide), cysteine (to disulfides and beyond), and tryptophan (to a range of products). Histidine and tyrosine are susceptible under harsher conditions.

Oxidation is driven by dissolved oxygen, light, and — critically — trace transition metals. Copper and iron contamination at parts-per-million catalyses it. If a protocol involves a metal-containing buffer and a methionine-bearing peptide, the two should not sit together longer than necessary.

The practical version: if your sequence contains Met, Cys or Trp, minimise headspace in the vial, keep it dark, and do not leave working solutions at the bench.

Hydrolysis — where the backbone breaks

Peptide bonds are kinetically stable at neutral pH, which is why hydrolysis is usually slow. The exception is Asp-Pro, which is markedly more labile than other bonds, particularly under acidic conditions. Asp-Gly is a secondary concern.

For most short research peptides in a properly stored solution, backbone hydrolysis is not the limiting factor. It matters when a peptide is held at extreme pH or elevated temperature.

Disulfide scrambling — only for cysteine-containing peptides

Peptides with two or more cysteines have a defined disulfide pattern, and that pattern is part of the active structure. In solution, particularly at higher pH, thiol–disulfide exchange can shuffle those bonds into alternative isomers with the same mass but different behaviour.

This is the trap: a scrambled peptide has an unchanged molecular weight. Mass spectrometry will not catch it. Only a separation method — HPLC retention time against a reference — will.

Aggregation and adsorption — the ones that look like nothing happened

Hydrophobic peptides self-associate, and the resulting aggregates may be invisible until they are large enough to scatter light. Shaking, vortexing and foaming all accelerate this by driving the peptide to the air–water interface. This is the reason for the universal advice to swirl rather than shake.

Adsorption is subtler and affects dilute solutions most. Peptides stick to glass and plastic. At low micromolar concentrations in a plain tube, a meaningful fraction of your material can end up on the wall rather than in solution — and your assay will read as a potency problem rather than a handling problem. Low-binding tubes, or a carrier protein where the assay tolerates one, address it.

Reading your own sequence for peptide storage risk

If the sequence contains The risk is Mitigation
Asn-Gly Rapid deamidation Keep pH below neutral; do not store in solution long-term
Met, Trp Oxidation Minimise headspace, protect from light, avoid trace metals
Two or more Cys Disulfide scrambling Store cold and slightly acidic; verify by HPLC, not MS alone
Asp-Pro Acid-catalysed backbone cleavage Avoid low pH and elevated temperature
A long hydrophobic run Aggregation Never shake; avoid repeated freeze–thaw
Any peptide, very dilute Surface adsorption Low-binding tubes; prepare working dilutions fresh

What this means for peptide storage in practice

  • Lyophilised, −20 °C, dark, dry. The powder is the stable form. Leave material lyophilised until you need it.
  • Let the vial reach room temperature before opening. Opening a cold vial pulls in humid air that condenses on the powder.
  • Reconstitute with bacteriostatic water when the vial will be entered repeatedly. Add the diluent down the wall, swirl, never shake.
  • Aliquot once, immediately. Every freeze–thaw cycle is a separate opportunity for aggregation and for concentration changes as ice forms.
  • Date the vial. Undated reconstituted material is unusable data a fortnight later.
  • Refrigerate working solutions, do not freeze them repeatedly, and treat the useful window as days to weeks rather than months.

The reconstitution method itself is covered step by step in the peptide reconstitution guide, and the difference between diluent types in our note on preserved versus unpreserved water.

Peptide storage: frequently asked questions

How long does a reconstituted peptide last?
There is no single answer, because it depends on the sequence, the diluent, the concentration and the temperature. Days to weeks refrigerated is a reasonable planning assumption for most short peptides; the lyophilised powder is the form to rely on for long-term storage.
Does a cloudy solution mean the peptide has degraded?
It means something has come out of solution — aggregation, or incomplete dissolution. More agitation is the wrong response; check concentration, pH and how it was mixed.
Why does everyone say not to shake the vial?
Shaking drives peptide to the air–water interface, which promotes aggregation, and creates foam that traps material. Swirling dissolves just as effectively without either.
Will mass spectrometry tell me if my peptide has degraded?
Sometimes. Deamidation and oxidation shift the mass and will show. Disulfide scrambling does not change the mass at all and requires a chromatographic method to detect.
Is it worth storing at −80 °C instead of −20?
For lyophilised short peptides, −20 °C is generally sufficient and the marginal gain is small. Avoiding freeze–thaw cycles matters more than the exact freezer temperature.

Related products

Degradation is one failure mode; refusing to dissolve in the first place is another. Our guide to peptide solubility covers how sequence charge predicts the right solvent.

References

The primary literature below is indexed on PubMed, and compound records are held at PubChem.

  1. Standard peptide and protein degradation chemistry: deamidation of asparagine and glutamine, sequence dependence of Asn-Gly, and pH dependence of the succinimide pathway.
  2. Oxidation of methionine, cysteine and tryptophan residues, including metal-catalysed oxidation.
  3. Acid-catalysed cleavage at Asp-Pro bonds in peptides and proteins.
  4. Thiol–disulfide exchange and disulfide scrambling in cysteine-containing peptides.
  5. Surface adsorption of peptides to glass and polypropylene at low concentration.
Research use only. All products sold by Soraci Labs are intended strictly for in-vitro laboratory research and are not for human or veterinary use, ingestion, injection, or any form of clinical application. Nothing on this page is medical advice or a claim of therapeutic benefit.

10 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *